Sign in
4

Changes in Ownership

COLLEGIUM PHARMACEUTICAL, INC Filed Acc 0001062993-23-022977

President and CEO sold 68,768 shares at an average $30.18 ($2,075,086)

  • President and CEO acquired 68,768 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Ciaffoni Joseph · President and CEO

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2023-12-18 Exercise or conversion : show line 1 in the form 10b5-1 +27,798 $21.34 $593,209 302,798 D
2023-12-18 Sale : show line 2 in the form 10b5-1 −27,798 $30.04 $834,935 275,000 D
2023-12-19 Exercise or conversion : show line 3 in the form 10b5-1 +14,516 $21.34 $309,771 289,516 D
2023-12-19 Sale : show line 4 in the form 10b5-1 −14,516 $30.03 $435,942 275,000 D
2023-12-20 Exercise or conversion : show line 5 in the form 10b5-1 +26,454 $21.34 $564,528 301,454 D
2023-12-20 Sale : show line 6 in the form 10b5-1 −26,454 $30.40 $804,210 275,000 D
Open-market sales · 68,768 sh · avg $30.18 · $2,075,086

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2023-12-18 Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (Right to Purchase) −27,798 62,202 D
2023-12-19 Exercise or conversion : show line 8 in the form 10b5-1 Stock Option (Right to Purchase) −14,516 47,686 D
2023-12-20 Exercise or conversion : show line 9 in the form 10b5-1 Stock Option (Right to Purchase) −26,454 21,232 D
Loading xslF345X05/form4.xml…